Argenx to acquire UNP for $550 million upfront plus contingent value rights tied to development and regulatory milestones, for total potential value of up ...
Ambrose Healthcare’s acquisition of AM-Pharma, valued at up to €161 million plus royalties, strengthens its rare disease pipeline and establishe...
Lonza, a global contract development and manufacturing organization, to acquire the CDMO business of Merck Transaction sharpens the focus of Merck&rsq...
Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced its acquisition of Solo Pace, Inc. (Solo Pace). Located in ...
Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced its acquisition of Solo Pace, Inc. (Solo Pace). Located in ...
Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced its acquisition of Solo Pace, Inc. (Solo Pace). Located in ...
Purchase price of $20 per ADS in cash represents an enterprise value of $1.1 billion and an equity value of approximately $1.3 billion Silence Therapeut...
Ambrose Healthcare, a rare disease specialist, has acquired 100% of the shares of AM-Pharma. Under the terms of the agreement, AM-Pharma's shareholders are...
Cotecna, a leading provider of Testing, Inspection and Certification (TIC) services, announced the acquisition of Energon Labs, a cGMP-compliant, USFDA-ins...
Acquisition brings together two highly complementary, science-backed skincare brands ZO Skin Health’s premium daily multi-step regimens complement...
Collaboration will combine Zealand Pharma’s expertise in metabolic health with Generate’s proprietary generative AI platform to create multis...
Biomapas, a leading integrated life sciences services provider, announces the acquisition of Pinnaxis, a global pharmacovigilance technology and consulting...
Ofichem has signed an agreement to acquire Kinentia Biosciences, a Drug Substance CDMO based in Rensselaer, New York. Completion of the transaction remains...
Samfara, a European life sciences investment firm, announced that it has completed the acquisition of Chr. Olesen Synthesis from Chr. Olesen and funds mana...
© 2026 Biopharma Boardroom. All Rights Reserved.
